31
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Accuracy of the Majority Voting Method with Multiple IOL Power Formulae

, , ORCID Icon, , ORCID Icon &
Pages 1341-1351 | Received 02 Jan 2024, Accepted 24 Apr 2024, Published online: 13 May 2024
 

Abstract

Purpose

This study aimed to evaluate the efficacy of a majority decision algorithm that integrates intraoperative aberrometry (IA) and two intraocular lens (IOL) frequency formulas. The primary objective was to compare the accuracy of three formulas (IA; Sanders, Retzlaff, and Kraff/Theoretical (SRK/T); and Barrett Universal II (BUII)), in achieving emmetropia in eyes implanted with TFNT lenses (Alcon).

Patients and Methods

A total of 145 eyes of 145 patients were included in the evaluation. Preoperative data were obtained from IOLMaster 700, while intraoperative data were collected from ORA SYSTEMTM. Visual acuity ≥0.8 at the 3-month post-surgery mark was confirmed. We assessed refractive prediction error (RPE), which is the difference between predicted refraction (PR) and postoperative subjective refraction. This evaluation aimed to identify the optimal IOL power with the implemented algorithm.

Results

Among the 145 eyes evaluated, 55.9%, 78.7%, and 97.2% achieved postoperative subjective refraction within ±0.13 Diopters (D), ±0.25 D, and ±0.50 D, respectively. The percentages of eyes within ±0.25 D of PR varied by formula type, with values of 57%, 57%, and 54% for IA, BUII, and SRK/T, respectively. For eyes with short to medium axial length (AL<26.00 mm), the percentages within ±0.25 D of RPE were 52%, 58%, and 58% for IA, SRK/T, and BUII, respectively. In contrast, for eyes with long axial length (≥26.00 mm) the percentages were 68%, 52%, and 45% for IA, BUII, and SRK/T, respectively.

Conclusion

The proposed majority decision algorithm incorporating IA and two IOL frequency formulas was effective in reducing postoperative refractive error. IA was particularly beneficial for eyes with long axial length. These findings suggest the algorithm has potential to optimize IOL power selection to improve quality of life of patients and clinical practice outcomes.

Acknowledgments

The authors are indebted to Mr Masato Morikawa for editing and reviewing this manuscript for English language and technical support, and to Mr David Price of English Services for Scientists for English proofreading.

Disclosure

Mr Yukihito Kato, Mr Yoshiki Tanaka, and Dr Kazuo Ichikawa report a patent P7291443 issued. Dr Takashi Kojima reports grants, personal fees from Alcon, personal fees from STAAR Surgical, Johnson & Johnson, and Santen pharmaceuticals, outside the submitted work. Dr Kazuo Ichikawa reports research expense from Alcon Japan Ltd, outside the submitted work. The authors report no other conflicts of interest in this work.